- Elevance Health Announces Appearance at Goldman Sachs 45th Annual Global Healthcare Conference
- Elevance Health Announces Appearance at Bernstein’s 40th Annual Strategic Decisions Conference
- Elevance Health Reports First Quarter 2024 Results
- Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
- Piedmont & Anthem Blue Cross and Blue Shield Extend Contract
- Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
More ▼
Key statistics
On Tuesday, Elevance Health Inc (ELV:NYQ) closed at 535.29, -2.73% below its 52-week high of 550.34, set on May 22, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 542.38 |
---|---|
High | 542.38 |
Low | 531.68 |
Bid | 497.60 |
Offer | 851.11 |
Previous close | 535.29 |
Average volume | 909.34k |
---|---|
Shares outstanding | 232.42m |
Free float | 231.50m |
P/E (TTM) | 20.23 |
Market cap | 124.41bn USD |
EPS (TTM) | 26.47 USD |
Annual div (ADY) | 6.52 USD |
---|---|
Annual div yield (ADY) | 1.20% |
Div ex-date | Jun 10 2024 |
Div pay-date | Jun 25 2024 |
Data delayed at least 15 minutes, as of Jun 26 2024 00:00 BST.
More ▼